z-logo
open-access-imgOpen Access
A novel splice site mutation in AP 1S2 gene for X‐linked mental retardation in a Chinese pedigree and literature review
Author(s) -
Huo Liang,
Teng Ziteng,
Wang Hua,
Liu Xueyan
Publication year - 2019
Publication title -
brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.915
H-Index - 41
ISSN - 2162-3279
DOI - 10.1002/brb3.1221
Subject(s) - mutation , genetics , nonsense mutation , hypotonia , microcephaly , etiology , medicine , intellectual disability , splice site mutation , gene , biology , missense mutation , exon , alternative splicing
Background Pettigrew syndrome ( PGS ) is a rare X‐linked mental retardation that caused by AP 1S2 mutation. The pathogenesis of AP 1S2 deficiency has remained elusive. The purpose of this study is to give a comprehensive overview of the phenotypic and genetic spectrum of AP 1S2 mutations. Methods This study systematically analyzed clinical features and genetic information of a Chinese family with AP 1S2 variation, and reviewed previously reported literatures with the same gene variation. Results We identified a new c.1‐1 G>C mutation in AP 1S2 gene from a four generation family with seven affected individuals and found the elevated neuron‐specific enolase ( NSE ) in a patient. We summarized the clinical manifestation of 59 patients with AP 1S2 mutation. We found that pathogenic point mutations affecting AP 1S2 are associated with dysmorphic features and neurodevelopmental problems, which included highly variable mental retardation ( MR ), delayed in walking, abnormal speech, hypotonia, abnormal brain, abnormal behavior including aggressive behavior, ASD , self‐abusive, and abnormal gait. Patients with splice site mutation were more likely to lead to seizures. By contrast, patients with nonsense mutations are more susceptible to microcephaly. Conclusion Our findings suggest AP 1S2 mutations contribute to a broad spectrum of neurodevelopmental disorders and are important in the etiological spectrum of PGS .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here